Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBREXAFUNGERP vs IBRUTINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IBREXAFUNGERP vs IBRUTINIB: Safety Overview

Metric IBREXAFUNGERP IBRUTINIB
Total FAERS Reports 129 75,087
Deaths Reported 6 12,580
Death Rate 4.7% 16.8%
Hospitalizations 9 24,920
Average Patient Age 44.4 yrs 71.2 yrs
% Female Patients 85.2% 39.2%
FDA Approval Date Jun 1, 2021 Aug 24, 2022
Manufacturer N/A Pharmacyclics LLC
Route N/A ORAL
Marketing Status Prescription Prescription